2seventy Bio Stock Equity Positions Weight
TSVT Stock | USD 4.60 0.04 0.88% |
2Seventy Bio fundamentals help investors to digest information that contributes to 2Seventy Bio's financial success or failures. It also enables traders to predict the movement of 2Seventy Stock. The fundamental analysis module provides a way to measure 2Seventy Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 2Seventy Bio stock.
2Seventy | Equity Positions Weight |
2Seventy Bio Company Equity Positions Weight Analysis
2Seventy Bio's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
2Seventy Equity Positions Weight Driver Correlations
Understanding the fundamental principles of building solid financial models for 2Seventy Bio is extremely important. It helps to project a fair market value of 2Seventy Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since 2Seventy Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 2Seventy Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 2Seventy Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
Competition |
According to the company disclosure, 2Seventy Bio has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
2Seventy Fundamentals
Return On Equity | -0.77 | ||||
Return On Asset | -0.22 | ||||
Profit Margin | (2.17) % | ||||
Operating Margin | (5.60) % | ||||
Current Valuation | 273.66 M | ||||
Shares Outstanding | 51.4 M | ||||
Shares Owned By Insiders | 2.50 % | ||||
Shares Owned By Institutions | 98.22 % | ||||
Number Of Shares Shorted | 6.48 M | ||||
Price To Book | 1.01 X | ||||
Price To Sales | 2.58 X | ||||
Revenue | 100.39 M | ||||
Gross Profit | (183.46 M) | ||||
EBITDA | (206.42 M) | ||||
Net Income | (217.57 M) | ||||
Cash And Equivalents | 357.93 M | ||||
Cash Per Share | 9.45 X | ||||
Total Debt | 256.67 M | ||||
Debt To Equity | 0.73 % | ||||
Current Ratio | 3.88 X | ||||
Book Value Per Share | 5.04 X | ||||
Cash Flow From Operations | (166.86 M) | ||||
Short Ratio | 4.06 X | ||||
Earnings Per Share | (4.42) X | ||||
Target Price | 11.0 | ||||
Number Of Employees | 274 | ||||
Beta | 1.85 | ||||
Market Capitalization | 234.41 M | ||||
Total Asset | 565.43 M | ||||
Retained Earnings | (511.22 M) | ||||
Working Capital | 177.99 M | ||||
Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether 2Seventy Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if 2Seventy Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about 2seventy Bio Stock. Highlighted below are key reports to facilitate an investment decision about 2seventy Bio Stock:Check out 2Seventy Bio Piotroski F Score and 2Seventy Bio Altman Z Score analysis. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for 2Seventy Stock analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.42) | Revenue Per Share 2.037 | Quarterly Revenue Growth (0.81) | Return On Assets (0.22) | Return On Equity (0.77) |
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.